Stephen Parodi, MDThe Permanente Federation and The Permanente Medical Group

    Dr. Parodi is the executive vice president of External Affairs, Communications, and Brand at The Permanente Federation, and is an associate executive director for The Permanente Medical Group (TPMG).

    As an executive vice president on the Federation’s National Permanente Leadership Team, Dr. Parodi has oversight over the Federation’s external affairs functions, which include government relations, public policy, communications, and brand strategy.

    At TPMG, Dr. Parodi’s areas of responsibility include patient safety, the care of complex patients, laboratory medicine, risk management, transgender health, nephrology, renal transplant services, and infectious disease. He also serves as a liaison for Kaiser Permanente’s engagement in local and international health care delivery initiatives.

    He has held several leadership roles including the chief of Infectious Disease and HIV Care director for the Napa Solano Service Area, chair of Infectious Disease for TPMG, chair of the Northern California Regional Infection Control Committee, chair of the KP HealthConnect Governance Committee, and regional medical director of Hospital Operations.

    Dr. Parodi practices as an infectious disease physician providing inpatient and outpatient consultation, HIV care, and travel medicine services. He has a special interest in the treatment and prevention of infections due to multidrug resistant organisms and hospital epidemiology. He led clinical projects related to the reduction of health care-acquired infections, antimicrobial stewardship, reduction in dialysis-related infections, and regional outbreak responses. His work in hospital operations has included programs such as enhanced recovery after surgery, patient blood management, observation medicine, and bedside multidisciplinary rounding.

    Dr. Parodi received his medical degree from Georgetown University, completed his internal medicine residency at Vanderbilt University Medical Center, and an infectious disease fellowship at the UCLA Affiliated Program in Infectious Disease. He is a fellow in the Infectious Disease Society of America and serves as a delegate to the California Medical Association for the Very Large Group Forum. He has served on Society for Healthcare Epidemiology of America committees related to public policy, government affairs, and antimicrobial stewardship. He actively collaborates with the California Department of Public Health and Centers for Disease Control on public health matters.

    Phillip Oravetz, MDAlka Atal-Barrio, MD, CAPP Board Member